Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Naloxone for Fentanyl-Induced Pruritus in Spinal Anesthesia
NCT04673812Completed
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Dec 2020
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of naloxone in opioid-induced pruritus (OIP) (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Incidence of fentanyl-induced pruritus at 4 hours. Started Dec 2020; status: completed.
02
Drugs
naloxone
03
Conditions
opioid-induced pruritus (OIP)
Beyond the preview
Go deeper on NCT04673812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04673812.